原文始发于微信公众号（药时代服务号）：Projects for Licensing | DrugTimes
PhaseII Bispecific Antibody Platform and Projects
PhaseIII Ophthalmology Project (Dry Eye, Postoperative Inflammation/Pain)
The world’s leading botanical drug R&D company: phase III hair loss products
PhaseIII First-in-class IAP antagonist for various cancers
If you are interested in these potential collaboration opportunities, please contact us.
More opportunities will be posted, please visit: www.drugtimes.cn